Yale University

Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.

TitleDesign and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community.
Publication TypeJournal Article
Year of Publication2013
AuthorsSpringer, Sandra A., Frederick L. Altice, Maua Herme, and Angela Di Paola
JournalContemporary clinical trials
Date Published2013 Dec 30
ISSN1559-2030
AbstractHIV-infected prisoners have a high prevalence of alcohol use disorders and commonly relapse to alcohol soon after release to the community which is linked to high morbidity, poor antiretroviral therapy (ART) adherence and increased sexual risk-taking behaviors. Extended-release naltrexone (XR-NTX) effectively reduces relapse to alcohol in alcohol dependent persons, yet it remains unexamined among criminal justice system (CJS) populations transitioning to the community.
DOI10.1016/j.cct.2013.12.006
Alternate JournalContemp Clin Trials

External Links